|
|
||||||||
Clinical |
Department of Pediatric Nephrology,1 University Medical Center, Utrecht, The Netherlands; Department of Pediatric Nephrology,2 Tygerberg Children's Hospital, Tygerberg, South Africa; Department of Pediatric Nephrology3 and Department of Clinical Chemistry,4 University Medical Center, Nijmegen, The Netherlands
Correspondence to: P. Nourse, PO Box 19063, Tygerberg 7505, South Africa. nourse{at}sun.ac.za
Objectives: Differences in peritoneal fluid handling in
the acute setting can be expected if children are converted to pH-neutral
dialysis solutions because conventional acidic solutions exert toxic effects
on peritoneal mesothelial cells and microcirculation. Peritoneal fluid
kinetics was therefore investigated with both types of solutions in a group of
children.
Design: Peritoneal equilibration tests (PETs) were
performed in 12 patients [mean age 70 months, mean time on peritoneal dialysis
(PD) 18 months] using a pH-neutral PD fluid (Physioneal 3.86%; Baxter Ltd,
Castlebar, Ireland) and dextran 70 as a volume marker. The results of these
PETs were compared to those of a historic group of 12 children (mean age 75
months, mean time on PD 17 months).
Setting: Pediatric dialysis unit in a tertiary
institute.
Patients: Stable pediatric PD patients.
Main Outcome Measures: Transcapillary ultrafiltration
(TCUF) and marker clearance, dialysate-to-plasma (D/P) ratios for urea and
creatinine, and Dt/D0 ratio for glucose.
Results: TCUF and lymphatic absorption were not
different between the two groups. There was also no significant difference in
small solute clearance measured by D/P ratio for urea and creatinine and
Dt/D0 ratio for glucose.
Conclusion: Peritoneal fluid kinetics is not
significantly altered if pH-neutral dialysis solutions are applied compared to
acidic solutions. An altered TCUF, as is hypothetically possible using an
acidic solution, was not established.
KEY WORDS: Peritoneal equilibration test; children; pH-neutral dialysis solution.
Received 8 March 2005; accepted 2 March 2006.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |